Human FXR Regulates SHP Expression Through Direct Binding to an LRH-1 Binding Site, Independent of an IR-1 and LRH-1

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Feb 6

PMID 24498423

Citations 23

Authors

Martijn O Hoeke

Janette Heegsma

Mark Hoekstra

Han Moshage

Klaas Nico Faber

Affiliations

Soon will be listed here.

Abstract

Background: Farnesoid X receptor/retinoid X receptor-alpha (FXR/RXRα) is the master transcriptional regulator of bile salt synthesis and transport in liver and intestine. FXR is activated by bile acids, RXRα by the vitamin A-derivative 9-cis retinoic acid (9cRA). Remarkably, 9cRA inhibits binding of FXR/RXRα to its response element, an inverted repeat-1 (IR-1). Still, most FXR/RXRα target genes are maximally expressed in the presence of both ligands, including the small heterodimer partner (SHP). Here, we revisited the FXR/RXRα-mediated regulation of human SHP.

Methods: A 579-bp hSHP promoter element was analyzed to locate FXR/chenodeoxycholic acid (CDCA)- and RXRα/9cRA-responsive elements. hSHP promoter constructs were analyzed in FXR/RXRα-transfected DLD-1, HEK293 and HepG2 cells exposed to CDCA, GW4064 (synthetic FXR ligand) and/or 9cRA. FXR-DNA interactions were analyzed by in vitro pull down assays.

Results: hSHP promoter elements lacking the previously identified IR-1 (-291/-279) largely maintained their activation by FXR/CDCA, but were unresponsive to 9cRA. FXR-mediated activation of the hSHP promoter was primarily dependent on the -122/-69 region. Pull down assays revealed a direct binding of FXR to the -122/-69 sequence, which was abrogated by site-specific mutations in a binding site for the liver receptor homolog-1 (LRH-1) at -78/-70. These mutations strongly impaired the FXR/CDCA-mediated activation, even in the context of a hSHP promoter containing the IR-1. LRH-1 did not increase FXR/RXRα-mediated activation of hSHP promoter activity.

Conclusion: FXR/CDCA-activated expression of SHP is primarily mediated through direct binding to an LRH-1 binding site, which is not modulated by LRH-1 and unresponsive to 9cRA. 9cRA-induced expression of SHP requires the IR-1 that overlaps with a direct repeat-2 (DR-2) and DR-4. This establishes for the first time a co-stimulatory, but independent, action of FXR and RXRα agonists.

Citing Articles

FXR-ApoC2 pathway activates UCP1-mediated thermogenesis by promoting the browning of white adipose tissues.

Kim S, Park W, Kim B, Kim J, Song G, Park J J Biol Chem. 2025; 301(3):108181.

PMID: 39798876 PMC: 11871442. DOI: 10.1016/j.jbc.2025.108181.

The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease.

Li Z, Zheng D, Zhang T, Ruan S, Li N, Yu Y Hepatol Commun. 2023; 8(1).

PMID: 38099854 PMC: 10727660. DOI: 10.1097/HC9.0000000000000343.

FXR Friend-ChIPs in the Enterohepatic System.

Meadows V, Yang Z, Basaly V, Guo G Semin Liver Dis. 2023; 43(3):267-278.

PMID: 37442156 PMC: 10620036. DOI: 10.1055/a-2128-5538.

Bile Acids Induce Neurite Outgrowth in Nsc-34 Cells via TGR5 and a Distinct Transcriptional Profile.

Ackerman H, Gerhard G Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259326 PMC: 9963315. DOI: 10.3390/ph16020174.

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease.

Yan C, Hu W, Tu J, Li J, Liang Q, Han S J Transl Med. 2023; 21(1):300.

PMID: 37143126 PMC: 10158301. DOI: 10.1186/s12967-023-04166-8.

References

Urizar N, Dowhan D, Moore D . The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem. 2000; 275(50):39313-7. DOI: 10.1074/jbc.M007998200. View

Lu T, REPA J, Mangelsdorf D . Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem. 2001; 276(41):37735-8. DOI: 10.1074/jbc.R100035200. View

Lee J, Seok S, Yu P, Kim K, Smith Z, Rivas-Astroza M . Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology. 2012; 56(1):108-17. PMC: 3343176. DOI: 10.1002/hep.25609. View

Chanda D, Park J, Choi H . Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. Endocr J. 2007; 55(2):253-68. DOI: 10.1507/endocrj.k07e-103. View

Kassam A, Miao B, Young P, Mukherjee R . Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J Biol Chem. 2003; 278(12):10028-32. DOI: 10.1074/jbc.M208312200. View

Denson L, Sturm E, Echevarria W, Zimmerman T, Makishima M, Mangelsdorf D . The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology. 2001; 121(1):140-7. DOI: 10.1053/gast.2001.25503. View

Chong H, Infante A, Seo Y, Jeon T, Zhang Y, Edwards P . Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Res. 2010; 38(18):6007-17. PMC: 2952856. DOI: 10.1093/nar/gkq397. View

Blokzijl H, Vander Borght S, Bok L, Libbrecht L, Geuken M, Van den Heuvel F . Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis. 2007; 13(6):710-20. DOI: 10.1002/ibd.20088. View

Chen W, Owsley E, Yang Y, Stroup D, Chiang J . Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. J Lipid Res. 2001; 42(9):1402-12. View

10.

Cai S, He H, Nguyen T, Mennone A, Boyer J . Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms. J Lipid Res. 2010; 51(8):2265-74. PMC: 2903807. DOI: 10.1194/jlr.M005546. View

11.

Wang Y, Chen W, Moore D, Huang W . FXR: a metabolic regulator and cell protector. Cell Res. 2008; 18(11):1087-95. DOI: 10.1038/cr.2008.289. View

12.

Forman B, Goode E, Chen J, Oro A, Bradley D, Perlmann T . Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995; 81(5):687-93. DOI: 10.1016/0092-8674(95)90530-8. View

13.

Song C, Echchgadda I, Baek B, Ahn S, Oh T, Roy A . Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem. 2001; 276(45):42549-56. DOI: 10.1074/jbc.M107557200. View

14.

Ueda H, Sun G, Murata T, Hirose S . A novel DNA-binding motif abuts the zinc finger domain of insect nuclear hormone receptor FTZ-F1 and mouse embryonal long terminal repeat-binding protein. Mol Cell Biol. 1992; 12(12):5667-72. PMC: 360506. DOI: 10.1128/mcb.12.12.5667-5672.1992. View

15.

Goodwin B, Jones S, Price R, Watson M, McKee D, Moore L . A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 2000; 6(3):517-26. DOI: 10.1016/s1097-2765(00)00051-4. View

16.

Matsukuma K, Wang L, Bennett M, Osborne T . A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor. J Biol Chem. 2007; 282(28):20164-71. DOI: 10.1074/jbc.M702895200. View

17.

Lee Y, Parker K, Choi H, Moore D . Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers. J Biol Chem. 1999; 274(30):20869-73. DOI: 10.1074/jbc.274.30.20869. View

18.

Lu T, Makishima M, REPA J, Schoonjans K, Kerr T, Auwerx J . Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 2000; 6(3):507-15. DOI: 10.1016/s1097-2765(00)00050-2. View

19.

Lee Y, Schmidt D, Cummins C, Choi M, Peng L, Zhang Y . Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol. 2008; 22(6):1345-56. PMC: 2409274. DOI: 10.1210/me.2007-0565. View

20.

Frankenberg T, Rao A, Chen F, Haywood J, Shneider B, Dawson P . Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol. 2005; 290(5):G912-22. DOI: 10.1152/ajpgi.00479.2005. View